Marlio Charles Mosseri - 23 Oct 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
23 Oct 2025
Net transactions value
+$957,083
Form type
4
Filing time
29 Oct 2025, 08:00:22 UTC
Previous filing
24 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 29 Oct 2025 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $284,214 +46,900 +1.6% $6.06 3,028,706 23 Oct 2025 By Emerald Hill Ventures SARL SPF. F1
transaction NVCT Common Stock Purchase $215,459 +35,034 +1.2% $6.15 3,063,740 24 Oct 2025 By Emerald Hill Ventures SARL SPF. F1
transaction NVCT Common Stock Purchase $457,410 +72,836 +2.4% $6.28 3,136,576 27 Oct 2025 By Emerald Hill Ventures SARL SPF. F1
holding NVCT Common Stock 109,321 23 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.